Ghrelin stimulates in vitro angiogenic capacity of rat cardiac microvascular endothelial cells

Chinese Journal of Cardiology

Volumn 40, Issue 1, 2012, Pages 50-56

  Wang, Li ^a   Chen, Qing Wei ^a   Li, Gui Qiong ^a   Ke, Da Zhi ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Ghrelin; Neovascularization,physiologic

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARDIAC MICROVASCULAR ENDOTHELIAL CELL; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GHRELIN; MALE; MAP KINASE SIGNALING SYSTEM; MICROVESSELS; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GHRELIN;

EID: 84862076745     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2012.01.011     Document Type: Article

References (24)

1. Matsumura K, Tsuchihashi T, Fujii K, et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension, 2002, 40: 694-699.
2. Lin Y, Matsumura K, Fukuhara M, et al. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension, 2004, 43: 977-982.
3. Li WG, Gavrila D, Liu X, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation, 2004, 109: 2221-2226.
4. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest, 2004, 114: 57-66.
5. Zhao H, Liu G, Wang Q, et al. Effect of ghrelin on human endothelial cells apoptosis induced by high glucose. Biochem Biophys Res Commun, 2007, 362: 677-681.
6. Tesauro M, Schinzari F, Iantorno M, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation, 2005, 112: 2986-2992.
7. Li A, Cheng G, Zhu GH, et al. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem Biophys Res Commun, 2007, 353: 238-243.
8. Ahluwalia A, Li A, Cheng G, et al. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol, 2009, 60: 29-34.
9. Kleinz MJ, Maguire JJ, Skepper JN, et al. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res, 2006, 69: 227-235.
10. Katugampola SD, Pallikaros Z, Davenport AP. [1251-His (9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol, 2001, 134: 143-149.
11. Iantorno M, Chen H, Kim JA, et al. Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab, 2007, 292: E756-E764.
12. Hedayati N, Annambhotla S, Jiang J, et al. Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg, 2009, 49: 199-207.
13. Nagaya N, Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol, 2003, 3: 146-151.
14. Konturek PC, Brzozowski T, Walter B, et al. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol, 2006, 536(1-2): 171-181.
15. Brzozowski T, Konturek PC, Sliwowski Z, et al. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther, 2006, 319: 477-487.
16. Yeh AH, Jeffery PL, Duncan RP, et al. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res, 2005, 11: 8295-8303.
17. Dixit VD, Weeraratna AT, Yang H, et al. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J Biol Chem, 2006, 281: 16681-16690.
18. Baiguera S, Conconi MT, Guidolin D, et al. Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med, 2004, 14: 849-854.
19. Conconi MT, Nico B, Guidolin D, et al. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides, 2004, 25: 2179-2185.
20. Ribatti D, Conconi MT, Nussdorfer GG. Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev, 2007, 59: 185-205.
21. Zaniolo K, Sapieha P, Shao Z, et al. Ghrelin modulates physiological and pathologic retinal angiogenesis through GHSR-1a. Invest Ophthalmol Vis Sci, 2011, 52: 5376-5386.
22. Wang Y, Narsinh K, Zhao L, et al. Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats. Cell Biol Int, 2010, 35: 135-140.
23. Goyal P, Behring A, Kumar A, et al. STK35L1 associates with nuclear actin and regulates cell cycle and migration of endothelial cells. PLoS One, 2011, 6: el6249.
24. Chaparro M, González Moreno L, Trapero-Marugán M, et al. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther, 2008, 28(11-12): 1269-1277.